0,759  0,004  5 Hydroxytryptamine release inhibitor
0,660  0,009  5 Hydroxytryptamine release stimulant
0,636  0,008  Histamine release inhibitor
0,601  0,007  GABA C receptor rho-3 antagonist
0,565  0,016  Antiprotozoal (Plasmodium)
0,558  0,011  Calcium channel L-type activator
0,527  0,030  Antiprotozoal
0,531  0,049  Caspase 9 stimulant
0,506  0,039  GST A substrate
0,486  0,031  Stroke treatment
0,474  0,025  CTGF expression inhibitor
0,448  0,032  FMO1 substrate
0,453  0,040  Cholesterol antagonist
0,428  0,043  Aldehyde oxidase inhibitor
0,405  0,021  Acute neurologic disorders treatment
0,393  0,027  Calcium channel activator
0,403  0,037  Aryl hydrocarbon receptor agonist
0,395  0,031  Cardiovascular analeptic
0,415  0,051  Vasodilator, peripheral
0,426  0,069  TNF expression inhibitor
0,411  0,059  CYP2C9 substrate
0,410  0,062  Antipruritic, allergic
0,345  0,011  5 Hydroxytryptamine 1E antagonist
0,358  0,023  5 Hydroxytryptamine uptake stimulant
0,345  0,017  Tyrosine 3 hydroxylase inhibitor
0,350  0,028  Peroxidase inhibitor
0,386  0,065  Ulceration
0,333  0,018  Antianorexic
0,349  0,037  FMO3 substrate
0,328  0,032  GST M1-1 substrate
0,338  0,044  Antihypoxic
0,342  0,048  UGT1A9 substrate
0,374  0,089  Antibacterial
0,311  0,026  Gastrin inhibitor
0,325  0,041  Antineoplastic (liver cancer)
0,324  0,043  Antidiabetic symptomatic
0,333  0,054  Interleukin 2 agonist
0,341  0,064  Antihypertensive
0,282  0,006  SULT1A1 substrate
0,366  0,091  15-Lipoxygenase inhibitor
0,321  0,046  Proliferative diseases treatment
0,324  0,050  Antineoplastic (endocrine cancer)
0,321  0,053  UGT2B4 substrate
0,333  0,064  AR expression inhibitor
0,275  0,008  GABA C receptor rho-2 antagonist
0,325  0,058  CYP2C19 substrate
0,323  0,060  Lipoxygenase inhibitor
0,269  0,011  Ferrochelatase inhibitor
0,262  0,004  Cathepsin L2 inhibitor
0,380  0,124  Apoptosis agonist
0,301  0,054  Antiprotozoal (Leishmania)
0,316  0,070  Antimycobacterial
0,296  0,056  Flavin-containing monooxygenase substrate
0,271  0,033  Antimutagenic
0,293  0,057  Transcription factor STAT3 inhibitor
0,268  0,032  Diabetic retinopathy treatment
0,267  0,033  Pneumotoxic
0,300  0,066  Antituberculosic
0,247  0,016  SULT1A3 substrate
0,283  0,057  Interleukin agonist
0,275  0,050  Psychostimulant
0,276  0,051  UGT1A6 substrate
0,232  0,010  Calcium antagonist
0,235  0,014  Catenin beta inhibitor
0,293  0,076  Antineoplastic (ovarian cancer)
0,258  0,046  Sedative
0,314  0,106  CYP2C9 inhibitor
0,257  0,050  Antihypotensive
0,246  0,041  Neurotrophic factor enhancer
0,222  0,019  Neurotrophic factor
0,211  0,009  Folate antagonist
0,272  0,072  Transcription factor STAT inhibitor
0,257  0,058  Calpain inhibitor
0,211  0,013  Coagulant
0,248  0,051  RNA-directed DNA polymerase inhibitor
0,204  0,007  GABA C receptor rho-1 antagonist
0,291  0,095  Vasodilator, coronary
0,245  0,049  Abortion inducer
0,227  0,031  CNS active muscle relaxant
0,267  0,071  Antihypercholesterolemic
0,257  0,062  Antineoplastic (sarcoma)
0,255  0,061  Cyclic AMP phosphodiesterase inhibitor
0,202  0,008  Prolactin inhibitor
0,199  0,013  GABA C receptor antagonist
0,259  0,075  DNA damaging
0,237  0,054  VCAM1 expression inhibitor
0,265  0,083  Insulysin inhibitor
0,261  0,079  CYP1A2 inhibitor
0,203  0,021  Antibacterial (Helicobacter pylori)
0,235  0,054  Antiviral (West Nile virus)
0,221  0,042  Antihelmintic (Nematodes)
0,183  0,004  Glycine receptor antagonist
0,242  0,063  Antiulcerative
0,340  0,162  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,239  0,061  Antiparkinsonian, rigidity relieving
0,224  0,046  Sepsis treatment
0,280  0,104  Thyroid hormone antagonist
0,216  0,040  5 Hydroxytryptamine 3E antagonist
0,184  0,010  Electron transport complex I inhibitor
0,225  0,051  Insulin sensitizer
0,244  0,071  Cardiodepressant
0,235  0,062  Antineoplastic enhancer
0,205  0,034  Uterine stimulant
0,275  0,107  Antineoplastic (small cell lung cancer)
0,200  0,032  Antiprotozoal (Coccidial)
0,183  0,017  Photosensitizer
0,205  0,041  Antineoplastic (squamous cell carcinoma)
0,177  0,015  Creatine kinase inhibitor
0,220  0,057  Non-steroidal antiinflammatory agent
0,245  0,083  Antineoplastic (bladder cancer)
0,216  0,056  CYP2B6 inhibitor
0,213  0,054  Growth hormone agonist
0,235  0,078  DNA synthesis inhibitor
0,272  0,117  CYP3A4 substrate
0,195  0,041  UGT2B10 substrate
0,204  0,050  VEGF expression inhibitor
0,178  0,024  Liver cirrhosis treatment
0,236  0,084  Superoxide dismutase inhibitor
0,288  0,137  CYP2C19 inhibitor
0,196  0,046  Hair growth stimulant
0,212  0,063  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,198  0,050  Succinate dehydrogenase inhibitor
0,202  0,055  Lipocortins synthesis antagonist
0,154  0,007  NMDA 2A receptor antagonist
0,229  0,083  NOS2 expression inhibitor
0,217  0,072  Cytotoxic
0,192  0,047  Antineoplastic (carcinoma)
0,262  0,118  Antineoplastic (lung cancer)
0,163  0,021  NMDA receptor antagonist
0,180  0,040  Antifungal enhancer
0,183  0,044  Genotoxic
0,162  0,024  Mediator release inhibitor
0,161  0,022  Ca2+-transporting ATPase inhibitor
0,197  0,060  Diabetic nephropathy treatment
0,185  0,048  Death-associated protein kinase 2 inhibitor
0,234  0,098  Chemoprotective
0,153  0,018  Antiprotozoal (Toxoplasma)
0,158  0,025  Antiviral (Papilloma)
0,146  0,013  CDC25A inhibitor
0,156  0,024  Gastric antisecretory
0,184  0,053  ATPase inhibitor
0,173  0,043  CF transmembrane conductance regulator agonist
0,167  0,037  Sphingosine 1-phosphate receptor 5 antagonist
0,227  0,097  Antioxidant
0,184  0,055  Muscular dystrophy treatment
0,232  0,104  Radiosensitizer
0,185  0,058  Antirickettsial
0,192  0,066  Antipruritic, non-allergic
0,138  0,013  Argininosuccinate synthase inhibitor
0,183  0,058  Phospholipase C inhibitor
0,249  0,124  Angiogenesis inhibitor
0,137  0,012  Interferon agonist
0,177  0,055  Phospholipase A2 inhibitor
0,219  0,097  Hypoglycemic
0,227  0,106  Radioprotector
0,150  0,028  AMP-activated protein kinase stimulant
0,174  0,053  Antiparkinsonian, tremor relieving
0,155  0,034  Sphingosine 1-phosphate receptor 2 antagonist
0,135  0,014  Myeloperoxidase inhibitor
0,216  0,096  Myocardial infarction treatment
0,161  0,041  Aldehyde dehydrogenase inhibitor
0,174  0,054  Antidote
0,177  0,057  Arachidonic acid antagonist
0,175  0,056  Neurotensin receptor agonist
0,246  0,129  Antithrombotic
0,137  0,019  NMDA 2 receptor antagonist
0,207  0,091  Teratogen
0,138  0,023  NAD(P)H dehydrogenase (quinone) inhibitor
0,237  0,122  Bone diseases treatment
0,160  0,046  Toll-Like receptor 2 antagonist
0,165  0,051  Tubulin antagonist
0,189  0,080  UGT1A1 substrate
0,241  0,134  Transcription factor NF kappa B inhibitor
0,143  0,036  TRPA1 agonist
0,138  0,032  Adenylate kinase inhibitor
0,260  0,155  Atherosclerosis treatment
0,127  0,022  Inducible nitric-oxide synthase inhibitor
0,156  0,053  Adenylate cyclase stimulant
0,166  0,063  Melanin inhibitor
0,151  0,049  Interleukin 4 antagonist
0,154  0,052  NADPH oxidase inhibitor
0,149  0,047  Cathepsin H inhibitor
0,111  0,009  Interferon inducer
0,200  0,100  Antineoplastic (glioma)
0,142  0,042  Microtubule formation inhibitor
0,233  0,136  Antineoplastic (osteosarcoma)
0,162  0,065  Carcinogenic, group 1
0,144  0,049  Adenylate cyclase inhibitor
0,164  0,069  Eye irritation, high
0,134  0,040  GST P1-1 substrate
0,244  0,149  Antineoplastic (breast cancer)
0,103  0,008  Histone deacetylase 7 inhibitor
0,133  0,038  Anticataract
0,107  0,013  Beta 3 adrenoreceptor antagonist
0,121  0,027  Antiviral (Rhinovirus)
0,193  0,100  Antineoplastic (lymphoma)
0,135  0,042  Protein kinase C gamma inhibitor
0,107  0,014  CDC25B inhibitor
0,191  0,099  Angiogenesis stimulant
0,152  0,059  Pancreatic disorders treatment
0,126  0,034  Nitric-oxide synthase inhibitor
0,159  0,067  Interferon gamma antagonist
0,210  0,118  Antiosteoporotic
0,144  0,053  DNA polymerase I inhibitor
0,219  0,129  CYP1A2 substrate
0,097  0,008  Sphingosine kinase inhibitor
0,177  0,089  Anesthetic general
0,198  0,111  Antineoplastic (renal cancer)
0,206  0,120  Antineoplastic (melanoma)
0,135  0,049  Sphingosine 1-phosphate receptor 4 antagonist
0,165  0,079  Dual specificity phosphatase inhibitor
0,143  0,057  Antiseptic
0,195  0,109  Vasodilator
0,117  0,032  Histamine N-methyltransferase inhibitor
0,100  0,017  NMDA receptor glycine site agonist
0,213  0,131  Antineoplastic (multiple myeloma)
0,094  0,012  Enoyl-[acyl-carrier-protein] reductase inhibitor
0,158  0,077  UGT1A3 substrate
0,180  0,100  Embryotoxic
0,192  0,112  Antineoplastic (non-small cell lung cancer)
0,173  0,093  Amyloid beta aggregation inhibitor
0,178  0,098  Antineoplastic (glioblastoma multiforme)
0,152  0,072  Hearing loss treatment
0,177  0,097  Ca2+/calmodulin-dependent kinase II beta inhibitor
0,148  0,070  Protein kinase stimulant
0,120  0,042  Antiviral (SARS coronavirus)
0,120  0,042  Antiviral (Coronavirus)
0,119  0,041  GST T1-1 substrate
0,148  0,071  Antidiabetic (type 1)
0,165  0,089  Carcinogenic
0,184  0,108  Antiglaucomic
0,121  0,047  Multidrug resistance-associated protein 1 inhibitor
0,129  0,056  Monophenol monooxygenase inhibitor
0,114  0,042  DNA directed RNA polymerase inhibitor
0,155  0,083  UGT1A4 substrate
0,175  0,103  Antihypertriglyceridemic
0,195  0,123  Immunostimulant
0,233  0,162  Calpain 2 inhibitor
0,129  0,059  Antiprotozoal (Amoeba)
0,207  0,136  CYP2D6 substrate
0,136  0,067  Nav1.2 sodium channel blocker
0,099  0,030  Glutamate decarboxylase inhibitor
0,093  0,025  Leukotriene antagonist
0,123  0,055  Cystathionine beta-synthase inhibitor
0,232  0,165  Immunosuppressant
0,079  0,012  Mineralocorticoid receptor antagonist
0,088  0,021  Maillard reaction inhibitor
0,078  0,012  NMDA receptor subunit 3A antagonist
0,196  0,131  Antineoplastic (pancreatic cancer)
0,089  0,023  Phospholipase D inhibitor
0,098  0,034  Telomerase inhibitor
0,102  0,038  Catalase inhibitor
0,077  0,014  NMDA receptor subunit 3B antagonist
0,072  0,009  Histamine H2 receptor agonist
0,206  0,144  Antifungal
0,197  0,135  Antineoplastic (colorectal cancer)
0,131  0,069  Antihemorrhagic
0,107  0,045  Lanosterol 14 alpha demethylase inhibitor
0,076  0,014  H+/K+-transporting ATPase inhibitor
0,086  0,025  NMDA receptor agonist
0,084  0,023  NMDA 2C receptor antagonist
0,129  0,068  Vanilloid 1 agonist
0,084  0,024  Beta adrenoreceptor antagonist
0,102  0,042  Restless leg syndrome treatment
0,148  0,089  UGT2B7 substrate
0,079  0,019  Fatty acid synthase inhibitor
0,110  0,050  Anabolic
0,174  0,115  Hypolipemic
0,104  0,045  Toll-Like receptor 3 antagonist
0,177  0,118  Antineoplastic (cervical cancer)
0,180  0,122  Cytostatic
0,123  0,065  Alkylator
0,083  0,025  Protease 3C (Human rhinovirus) inhibitor
0,065  0,008  Sphingosine kinase 1 inhibitor
0,097  0,040  Granulocyte macrophage colony stimulating factor agonist
0,166  0,110  Platelet aggregation inhibitor
0,104  0,048  Alcohol dehydrogenase inhibitor
0,128  0,072  Renal failure treatment
0,109  0,054  Sulfotransferase substrate
0,065  0,010  Histone deacetylase 9 inhibitor
0,071  0,016  Antiviral (Herpesvirus 3, Human)
0,186  0,132  Antineoplastic (colon cancer)
0,113  0,059  Carcinogenic, group 2B
0,139  0,086  MAP kinase kinase 4 inhibitor
0,090  0,037  Cathepsin G inhibitor
0,075  0,022  Acetyl-CoA transferase inhibitor
0,130  0,077  Bone formation stimulant
0,110  0,058  UGT2B1 substrate
0,126  0,074  Antihelmintic (Trematoda)
0,060  0,009  Histamine H1 receptor agonist
0,079  0,028  Glutamate (mGluR7) antagonist
0,087  0,038  HIV-1 reverse transcriptase inhibitor
0,103  0,054  UGT2B11 substrate
0,060  0,011  Nicotinic acid receptor agonist
0,145  0,097  Male reproductive disfunction treatment
0,107  0,060  GABA C receptor agonist
0,132  0,085  Acaricide
0,056  0,010  Angiotensin AT1 receptor antagonist
0,125  0,078  Amylase inhibitor
0,107  0,062  NAT2 substrate
0,096  0,050  Aminoacyl-tRNA synthetase inhibitor
0,128  0,083  Nav1.6 sodium channel blocker
0,056  0,011  Acid-sensing ion channel blocker
0,149  0,103  3C-like protease (Human coronavirus) inhibitor
0,169  0,124  Free radical scavenger
0,075  0,030  Aromatase inhibitor
0,117  0,073  Antiviral (Influenza B)
0,102  0,058  Sphingomyelinase inhibitor
0,084  0,040  SULT1A2 substrate
0,123  0,080  Skin whitener
0,064  0,021  Leukotriene C antagonist
0,058  0,015  Cytokine production stimulant
0,120  0,079  Antihyperlipoproteinemic
0,065  0,025  Nicotinic receptor alpha7 subunit antagonist
0,062  0,022  Immunoglobulin Fc receptor antagonist
0,109  0,069  Acetylcholine release stimulant
0,167  0,128  Platelet antagonist
0,110  0,071  Aldehyde dehydrogenase substrate
0,092  0,054  Ornithine decarboxylase inhibitor
0,103  0,065  Glutathione S-transferase substrate
0,060  0,022  Lysophosphatidic acid 3 receptor antagonist
0,076  0,038  Acetylcholine M5 receptor agonist
0,144  0,107  Sensitization
0,195  0,158  12-Lipoxygenase inhibitor
0,051  0,014  Glucocorticoid antagonist
0,111  0,075  Interleukin 8 antagonist
0,066  0,030  Beta 1 adrenoreceptor antagonist
0,040  0,004  Melatonin receptor 1A antagonist
0,125  0,090  UGT2B15 substrate
0,130  0,095  Acetylcholine M1 receptor antagonist
0,087  0,052  Histamine H2 receptor antagonist
0,119  0,085  Toll-Like receptor antagonist
0,044  0,010  Angiotensin II receptor antagonist
0,053  0,019  Geranyltranstransferase inhibitor
0,094  0,060  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,092  0,059  Thioredoxin inhibitor
0,038  0,006  Nicotinic acid receptor 2 antagonist
0,086  0,054  3C-Like protease (SARS coronavirus) inhibitor
0,050  0,018  Progesterone antagonist
0,113  0,082  Contraceptive female
0,077  0,047  Adenosine A3 receptor antagonist
0,129  0,099  Mutagenic
0,154  0,124  Anticonvulsant
0,054  0,024  Cholesterol esterase inhibitor
0,035  0,005  Acid ceramidase inhibitor
0,039  0,010  Melatonin antagonist
0,109  0,080  Shock treatment
0,191  0,162  NOS3 expression inhibitor
0,101  0,073  Excitatory amino acid transporter EAAC1 inhibitor
0,060  0,032  Acetyl-CoA transferase 2 inhibitor
0,174  0,146  Lipoprotein disorders treatment
0,064  0,036  Carbonic anhydrase stimulant
0,078  0,050  CYP2A6 inhibitor
0,108  0,080  Antiprotozoal (Babesia)
0,069  0,042  5 Hydroxytryptamine 1B antagonist
0,173  0,146  Nitric-oxide synthase stimulant
0,070  0,044  Sphingosine 1-phosphate receptor 4 agonist
0,048  0,022  GABA B receptor antagonist
0,047  0,021  Acetyl-CoA transferase 1 inhibitor
0,088  0,062  Triose-phosphate isomerase inhibitor
0,039  0,014  Histamine H3 receptor agonist
0,129  0,105  UGT2B9 substrate
0,075  0,051  Vanilloid 4 agonist
0,050  0,026  Adenylate cyclase 1 inhibitor
0,135  0,111  Cystic fibrosis treatment
0,064  0,040  Antimycoplasmal
0,091  0,068  Alpha 2d adrenoreceptor antagonist
0,164  0,141  Antipyretic
0,105  0,081  Proteasome inhibitor
0,063  0,040  Prolactin release inhibitor
0,053  0,030  Potassium channel (Inward rectifier) activator
0,034  0,011  NMDA receptor glycine site antagonist
0,111  0,088  Acetylcholinesterase inhibitor
0,097  0,074  Beta glucuronidase inhibitor
0,049  0,027  Purinergic P2Y antagonist
0,042  0,020  Leukotriene C4 antagonist
0,037  0,015  Calcium-independent phospholipase A2 inhibitor
0,050  0,028  Benzodiazepine antagonist
0,050  0,029  Potassium channel (ATP-sensitive) activator
0,114  0,093  Erectile dysfunction treatment
0,091  0,069  Butyrylcholinesterase inhibitor
0,039  0,018  1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor
0,095  0,075  Falcipain 3 inhibitor
0,086  0,065  Antidote, mercury
0,087  0,067  Paget's disease treatment
0,091  0,071  MAO A inhibitor
0,105  0,085  Autism spectrum disorders treatment
0,076  0,056  Estrogen receptor alpha antagonist
0,032  0,012  Dopamine autoreceptor agonist
0,186  0,167  Thyroid hormone beta antagonist
0,122  0,103  Antiviral (Influenza A)
0,057  0,038  Pregnane X receptor antagonist
0,022  0,004  Melatonin 2 antagonist
0,055  0,037  GABA receptor antagonist
0,067  0,049  Endocannabinoid uptake inhibitor
0,119  0,100  Antiischemic, cerebral
0,052  0,034  Beta 2 adrenoreceptor antagonist
0,122  0,103  Chemopreventive
0,096  0,078  Alpha 2b adrenoreceptor antagonist
0,040  0,023  Cholecystokinin B agonist
0,097  0,080  5 Hydroxytryptamine 3A agonist
0,110  0,093  Antifungal (Pneumocystis)
0,076  0,059  Acetylcholine nicotinic antagonist
0,053  0,036  Histamine agonist
0,067  0,050  Gaucher disease treatment
0,025  0,008  Melatonin 1 antagonist
0,090  0,074  Electrolyte absorption antagonist
0,120  0,104  Corneal wound healing stimulator
0,035  0,020  Melatonin receptor 1A agonist
0,053  0,038  GABA A receptor antagonist
0,065  0,050  Glutamate (mGluR6) antagonist
0,065  0,051  Antihemophilic
0,064  0,050  Neuronal nicotinic receptor antagonist
0,057  0,042  Cathepsin L inhibitor
0,073  0,058  Nicotinic alpha4beta2 receptor antagonist
0,065  0,051  Cyclin B3 inhibitor
0,162  0,148  Antiviral (Ebola)
0,073  0,060  GABA B receptor agonist
0,073  0,061  Macrophage migration inhibitory factor inhibitor
0,067  0,055  Phosphodiesterase V inhibitor
0,088  0,076  Interleukin 12 antagonist
0,100  0,088  Cholesterol synthesis inhibitor
0,034  0,022  Melatonin 1 agonist
0,062  0,051  Histone deacetylase inhibitor
0,068  0,057  Porphobilinogen synthase inhibitor
0,060  0,049  Histone deacetylase SIRT3 inhibitor
0,031  0,020  Histone deacetylase 10 inhibitor
0,181  0,171  CYP2D6 inhibitor
0,045  0,035  Phosphodiesterase 6C inhibitor
0,026  0,016  Lysophosphatidic acid receptor 1 agonist
0,026  0,016  Vanilloid 2 agonist
0,030  0,021  Lysophosphatidic acid 2 receptor antagonist
0,078  0,068  Androgen antagonist
0,057  0,048  Phosphodiesterase 1A inhibitor
0,124  0,115  Muscle relaxant
0,058  0,049  5 Hydroxytryptamine 5A antagonist
0,079  0,070  CC chemokine 5 receptor agonist
0,054  0,047  Prostaglandin EP2 antagonist
0,124  0,116  Antifungal (Cryptococcus)
0,038  0,031  Dopamine D5 agonist
0,055  0,048  Androgen agonist
0,050  0,043  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,050  0,043  Nicotinic alpha3beta2 receptor antagonist
0,101  0,095  Glutamate receptor antagonist
0,136  0,129  Pyruvate kinase inhibitor
0,037  0,030  Cathepsin L1 inhibitor
0,022  0,015  Angiotensin AT1A receptor antagonist
0,031  0,025  Melatonin agonist
0,030  0,023  Histone deacetylase 11 inhibitor
0,030  0,023  Histone deacetylase class IV inhibitor
0,121  0,115  Thiol protease inhibitor
0,074  0,070  Antispirochetal
0,082  0,077  Breast cancer-resistant protein inhibitor
0,022  0,017  Bombesin agonist
0,062  0,057  Potassium channel (ATP-sensitive) blocker
0,109  0,105  Lipid peroxidase inhibitor
0,097  0,094  MAO inhibitor
0,019  0,016  Toll-Like receptor 8 agonist
0,050  0,047  Glucosylceramidase inhibitor
0,051  0,048  Adenosine A1 receptor antagonist
0,017  0,015  Apical sodium codependent bile acid transporter inhibitor
0,029  0,027  ATP citrate lysase inhibitor
0,179  0,178  Hepatic disorders treatment
0,017  0,016  Bombesin 3 receptor agonist
0,066  0,064  Peroxisome proliferator-activated receptor gamma antagonist
0,143  0,142  Antiparasitic
0,149  0,149  Antiamyloidogenic
0,011  0,010  Glucocorticoid agonist
0,057  0,056  Antiviral (Parainfluenza)
0,097  0,097  Caspase 3 inhibitor

